Peijia Medical Limited (HKG: 9996)
Hong Kong
· Delayed Price · Currency is HKD
3.900
+0.050 (1.30%)
Nov 15, 2024, 4:08 PM HKT
Peijia Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Net Income | -251.74 | -392.53 | -407.81 | -574.22 | -2,069 | -531.98 | Upgrade
|
Depreciation & Amortization | 44.5 | 40.2 | 33.98 | 26.33 | 19.08 | 13.2 | Upgrade
|
Other Amortization | 3.7 | 2.61 | 2.03 | 1.15 | 0.4 | 0.14 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.22 | 0.22 | 0.03 | 0.22 | 0.38 | 0.29 | Upgrade
|
Loss (Gain) From Sale of Investments | -4.05 | -4.05 | -0.58 | -0.68 | -3.7 | - | Upgrade
|
Loss (Gain) on Equity Investments | 0.28 | 0.28 | 0.17 | - | - | - | Upgrade
|
Stock-Based Compensation | 28.25 | 28.25 | 27.95 | 30.93 | 36.66 | 113.75 | Upgrade
|
Other Operating Activities | 287.22 | 4.48 | -100.47 | 65.89 | 1,895 | 305.83 | Upgrade
|
Change in Inventory | -44.47 | -44.47 | -63.06 | -40.82 | -14.12 | -4.14 | Upgrade
|
Change in Accounts Payable | -258.97 | -258.97 | 193.53 | 79.36 | -10.42 | -23.18 | Upgrade
|
Change in Unearned Revenue | 11.38 | 11.38 | 0.35 | -1.91 | -0.31 | -0.03 | Upgrade
|
Change in Other Net Operating Assets | 29.11 | 29.11 | -62.32 | -22.62 | -35.15 | 23.53 | Upgrade
|
Operating Cash Flow | -154.55 | -583.49 | -376.2 | -436.37 | -181.1 | -102.59 | Upgrade
|
Capital Expenditures | -149.53 | -175.62 | -130.41 | -69.74 | -25.25 | -13.47 | Upgrade
|
Sale of Property, Plant & Equipment | 0.04 | 0.25 | 0.06 | 0.01 | 0.02 | 0.23 | Upgrade
|
Cash Acquisitions | - | - | - | - | - | 59.62 | Upgrade
|
Sale (Purchase) of Intangibles | -0.61 | -140.56 | -71.93 | -123.3 | -0.7 | -0.06 | Upgrade
|
Investment in Securities | -1.94 | -42.98 | -244.08 | -224.11 | 11.74 | -15 | Upgrade
|
Other Investing Activities | -4.16 | -27.38 | -16.92 | -7.62 | 1.71 | 0.63 | Upgrade
|
Investing Cash Flow | -156.2 | -386.29 | -463.28 | -424.76 | -12.48 | 31.96 | Upgrade
|
Long-Term Debt Issued | - | 146.48 | 126.69 | - | - | - | Upgrade
|
Total Debt Issued | 64.23 | 146.48 | 126.69 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -59.41 | -3.37 | -3.16 | -1.92 | -18.06 | Upgrade
|
Total Debt Repaid | -3.55 | -59.41 | -3.37 | -3.16 | -1.92 | -18.06 | Upgrade
|
Net Debt Issued (Repaid) | 60.68 | 87.07 | 123.32 | -3.16 | -1.92 | -18.06 | Upgrade
|
Issuance of Common Stock | 1.31 | 4.06 | 2.11 | 813.93 | 2,376 | 21.57 | Upgrade
|
Repurchase of Common Stock | -26.69 | - | -5.18 | -64.72 | -24.75 | -19.22 | Upgrade
|
Other Financing Activities | -7.59 | -6.01 | -2.81 | -4.07 | -6.8 | -3.94 | Upgrade
|
Financing Cash Flow | 27.7 | 85.11 | 117.44 | 741.98 | 2,342 | 475.74 | Upgrade
|
Foreign Exchange Rate Adjustments | -8.25 | 10.77 | 95.59 | -42.91 | -194.99 | 4.76 | Upgrade
|
Net Cash Flow | -291.3 | -873.9 | -626.45 | -162.05 | 1,954 | 409.87 | Upgrade
|
Free Cash Flow | -304.08 | -759.11 | -506.61 | -506.11 | -206.35 | -116.06 | Upgrade
|
Free Cash Flow Margin | -58.76% | -172.08% | -201.97% | -370.68% | -533.84% | -620.68% | Upgrade
|
Free Cash Flow Per Share | -0.45 | -1.12 | -0.75 | -0.76 | -0.44 | -0.51 | Upgrade
|
Cash Interest Paid | 7.76 | 6.18 | 3.12 | 0.19 | 2.39 | 0.42 | Upgrade
|
Cash Income Tax Paid | 5.09 | 3.44 | 9.57 | - | - | - | Upgrade
|
Levered Free Cash Flow | -251.86 | -861.09 | -73.89 | -250.08 | -157.37 | -10.8 | Upgrade
|
Unlevered Free Cash Flow | -251.74 | -860.98 | -72.45 | -249.96 | -157.31 | -10.28 | Upgrade
|
Change in Net Working Capital | 0.53 | 411.45 | -267.88 | -32.08 | 57.05 | -14.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.